ArticleJournal of experimental & clinical cancer research : CR2020

MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1.

Enrica Vescarelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.